Hudson Bay Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-606,808
| Closed | -$80.1M | – | 1269 |
|
|
2025
Q1 | $80.1M | Buy |
606,808
+541,759
| +833% | +$71.5M | 0.25% | 50 |
|
|
2024
Q4 | $5.43M | Sell |
65,049
-14,951
| -19% | -$1.25M | 0.02% | 349 |
|
|
2024
Q3 | $5.85M | Sell |
80,000
-25,000
| -24% | -$1.83M | 0.02% | 278 |
|
|
2024
Q2 | $7.19M | Buy |
105,000
+75,000
| +250% | +$5.14M | 0.03% | 237 |
|
|
2024
Q1 | $2.08M | Buy |
30,000
+5,000
| +20% | +$346K | 0.01% | 377 |
|
|
2023
Q4 | $1.79M | Sell |
25,000
-10,000
| -29% | -$716K | 0.01% | 401 |
|
|
2023
Q3 | $1.82M | Buy |
+35,000
| New | +$1.82M | 0.01% | 423 |
|
|
2020
Q3 | – | Sell |
-20,000
| Closed | -$513K | – | 629 |
|
|
2020
Q2 | $513K | Sell |
20,000
-111,036
| -85% | -$2.85M | 0.01% | 398 |
|
|
2020
Q1 | $2.01M | Buy |
+131,036
| New | +$2.01M | 0.05% | 256 |
|